Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Real-time Estimate Cboe BZX 19:29:58 30/05/2024 BST 5-day change 1st Jan Change
509.6 USD +0.82% Intraday chart for Elevance Health, Inc. -6.31% +8.07%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
JPMorgan Adjusts Price Target on Elevance Health to $631 From $628 MT
Baird Initiates Elevance Health With Outperform Rating, $649 Price Target MT
US health insurer shares fall after UnitedHealth flags Medicaid medical use RE
Sector Update: Health Care Stocks Retreat Wednesday Afternoon MT
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues RE
Health Insurance Stocks Drop as UnitedHealth Flags 'Disturbance' in Medicaid MT
Transcript : Elevance Health, Inc. - Shareholder/Analyst Call
Factbox-Biggest cyber attacks in US healthcare sector RE
Argus Raises Elevance Health's Price Target to $600 From $540 MT
GroundGame.Health, Inc. announced that it has received $17 million in funding from 7wire Ventures, Elevance Health, Inc. CI
HCA beats first-quarter profit estimates on higher patient admissions RE
Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing MT
Molina Healthcare beats profit estimates aided by higher premiums RE
Mizuho Adjusts Price Target on Elevance Health to $585 From $575 MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555 MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629 MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565 MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602 MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578 MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating MT
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading MT
Chart Elevance Health, Inc.
More charts
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.). Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system. At the end of 2023, the group had nearly 47 million medical members.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
505.5 USD
Average target price
605.7 USD
Spread / Average Target
+19.82%
Consensus
  1. Stock Market
  2. Equities
  3. ELV Stock
  4. News Elevance Health, Inc.
  5. Insider Trends: 90-Days of Insider Buying at Anthem Interrupted with Share Disposition